We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Improved Battlefield Care Decreases Combat Mortality

By HospiMedica International staff writers
Posted on 16 Apr 2019
Increased use of tourniquets, blood transfusions, and speedier prehospital transport time accounted for 44.2% of the total mortality reduction seen over time in Afghanistan and Iraq, according to a new study.

Researchers from the U.S. More...
Army Medical Research & Materiel Command (MRMC; Fort Detrick, MD, USA), the U.S. Defense Health Agency (DHA; Falls Church, VA, USA), the University of Texas Health Science Center (San Antonio, USA), and other institutions conducted a retrospective analysis of data on all 56,763 U.S. casualties and soldiers injured in battle in Afghanistan and Iraq from October 2001 to December 31, 2017.

Casualty outcomes were compared over different periods of time with ratios of the use of tourniquets, blood transfusions, and transport to a surgical facility within 60 minutes. Main outcomes and measures were casualty status--alive, killed in action (KIA), or died of wounds (DOW)--and case-fatality rate (CFR). The researchers found that from early to later stages of the conflicts, CFR decreased in Afghanistan (from 20 to 8.6%), and in Iraq (from 20.4 to 10.1%). For critically injured casualties, survival increased in Afghanistan (from 2.2 to 39.9%) and in Iraq (from 8.9 to 32.9%).

In simulations using data from 23,699 individual casualties, without the interventions assessed, CFR would likely have been higher in Afghanistan and Iraq, equivalent to 3,672 additional deaths. Of these deaths, 44.2% were associated with the interventions studied: 12.9% with use of tourniquets, 23.8% for blood transfusions, and 7.5% for reduction in prehospital transport times. In all, a three-fold increase in survival among the most critically injured casualties was observed during the course of the conflicts. The study was published on March 27, 2019, in JAMA Surgery.

“Across 16 years of conflict, military trauma system advancements, namely, improvements in methods to control bleeding, replace blood, and reduce time to treatment, may be associated with increased survival of battle casualties,” concluded lead author Jeffrey Howard, PhD, of UTHSCSA, and colleagues. “More critically injured casualties reached surgical care, with increased survival, implying improvements in prehospital and hospital care.”

Related Links:
U.S. Army Medical Research & Materiel Command
U.S. Defense Health Agency
University of Texas Health Science Center


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ultrasound Needle Guidance System
SonoSite L25
Pressure Guidewire
SavvyWire
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.